The AJMC® HIV compendium is a comprehensive resource for clinical news and expert insights for the condition, including disparities in care, prevention of infection among at-risk groups, and the importance of viral suppression.
March 12th 2025
Cabotegravir was found to prevent HIV acquisition as a monotherapy pre-exposure prophylaxis (PrEP) and to treat HIV as a combination antiretroviral therapy (ART) in its long-acting injectable form.
HBV Vaccine Recommendations, Catch-Up Efforts Decreased Infection Rate in Patients With HIV
October 4th 2023Prevalence of hepatitis B virus (HBV) decreased in people living with HIV in Germany when vaccination coverage increased due to general recommendations and catch-up vaccination efforts.
Read More
Need for PrEP Support Services Persists Among Latino MSM
October 4th 2023Among Latino men who have sex with men (MSM), access to and use of pre-exposure prophylaxis (PrEP) remain at suboptimal levels, despite this population of individuals having disproportionately high rates of diagnosed HIV in the United States.
Read More
Incidence Rate of Tuberculosis Among Individuals With HIV in Africa Higher Than Estimated
September 19th 2023The World Health Organization 2022 Africa regional report underestimated the incidence rate of tuberculosis in sub-Saharan African individuals living with HIV, according to a recent analysis.
Read More
Study: Financial Incentives Increase PrEP Initiation, Adherence for HIV
September 15th 2023Applying novel and effective approaches based on behavioral economics for pre-exposure prophylaxis (PrEP) dissemination programs could help to tailor the programs to the populations and settings of areas with high HIV burden.
Read More
Patients Have Low Risk of Sexually Transmitting HIV With Viral Loads Less Than 1000 Copies/mL
July 28th 2023Evidence shows almost zero risk of sexual transmission when HIV viral loads are less than 1000 copies/mL, which could allow providers to destigmatize HIV and promote antiretroviral therapy adherence.
Read More
Limited Data Available on HPV Vaccine Immunogenicity, Efficacy in People Living With HIV
July 13th 2023Researchers summarized the limited available data on human papillomavirus (HPV) vaccine efficiency and immunogenicity in people living with HIV and gave insight into topics for further research.
Read More